Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

NCT02626845 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment

Conditions

Granulomatosis With Polyangiitis (Wegener's Granulomatosis)

Interventions

DRUG: Rituximab
OTHER: Placebo

Sponsor

Hospital for Special Surgery, New York

Collaborators

[object Object]
[object Object]